Of all the ways AI tools can help revolutionize healthcare, the most important isn’t about complex code or the latest breakthroughs—it’s about where care happens. Together, clinicians and AI are making the home the primary care site. AI acts as the analytical layer that turns a mountain of raw home data into a clear clinical picture. By using machine learning algorithms to identify subtle patterns in vital signs that the human eye might miss, AI allows remote patient monitoring (RPM) to move beyond simple data collection and into predictive, preventative care.
The era of people having to go to a medical facility for routine tests is coming to an end thanks to RPM, which enables real-time monitoring of vital signs—such as heart rate, blood pressure, weight, and blood glucose—to manage chronic conditions such as cardiovascular disease (CVD). AI is the engine behind this shift, instantly triaging these readings to flag anomalies, like a sudden arrhythmia or a dangerous spike in blood pressure, ensuring that doctors only see the most critical data points while patients receive immediate peace of mind.
CVD is the leading cause of death in the United States and worldwide. Every year, millions of lives are lost to CVD. Yet, 90% of CVD could be prevented through healthier diets and exercise.
As an engineer, I see the heart as the single point of failure in the system that is the human body. The key is to empower as many people as possible to discover when their hearts are in danger before a crisis occurs and to guide them to taking steps in the right direction from the comfort of their home.
HOME CARE IS MORE COMMON
RPM is a rapidly growing industry, expected to hit $67 billion this year, and nearly double to $118 billion by 2033. “Rapid adoption of connected health platforms, combined with rising prevalence of chronic diseases and supportive reimbursement policies, is accelerating the shift from episodic in-clinic care to continuous home-based monitoring,” Persistence Market Research reports. Changes in reimbursement codes are also driving growth in RPM.
This year, new codes covering digital health, AI, and remote monitoring were introduced, recognizing more types of RPM and shorter durations of use. Specifically, insurance providers are now approving coverage for monitoring periods as short as a few days rather than requiring a full month of data. This matters because it allows for “spot-check” diagnostic monitoring during acute symptoms, making these tools accessible for temporary recovery or early-stage screening rather than just long-term chronic management. As a result, RPM will be more widely available and more routinely recommended by healthcare providers.
By enabling condition-specific monitoring at home, these services can help diagnose, treat, and manage conditions earlier, potentially avoiding downstream complications, higher costs, and unnecessary acute-care visits. This not only reduces cost and stress for patients, but also engages people in their ongoing care in ways that can reduce or prevent more costly medical visits over time.
DELIVER TRUSTWORTHY DATA
As more people turn to digital health tools, it’s incumbent on the RPM industry to ensure that information collected at home is up to the highest possible standards for both clinical accuracy and data privacy. For example, at AliveCor, our Kardia personal electrocardiogram (ECG) records a medical-grade ECG on a patient’s smartphone or tablet, helping patients to better understand their own data, show trends and insights, and make actionable recommendations.
This medical-grade accuracy is vital because it bridges the gap between wellness tracking and clinical intervention. When a device provides actionable recommendations—such as prompting a patient to contact their cardiologist based on a specific ECG finding—those insights must be rooted in medical-grade, clinically accurate data.
Other RPM tools track blood pressure, glucose levels, and blood oxygen. The information these devices gather can be sent automatically to doctors and other healthcare providers to analyze. Patients no longer have to travel to healthcare facilities for testing. For people who live far from a medical practice, RPM is sometimes the only way they can get a test done at all.
These tools can also connect patients with a live healthcare adviser and enable them to use generative AI to answer non-medical questions. By typing into a secure chat interface within an app, patients can ask questions like, “What are some heart-healthy recipes that are low in sodium?” or “How can I better manage my stress?” This provides support for the lifestyle factors that represent 90% of heart health, without burdening the clinical staff with administrative or general wellness queries.
For patients to embrace these new tools, providers must ensure robust privacy and security measures. At AliveCor, we prioritize this through end-to-end encryption and strict adherence to HIPAA standards, ensuring that a patient’s most sensitive cardiac data is accessible only to them and their chosen care team. We were also among the first to achieve ISO 42001 certification for our AI Management System; it’s a rigorous validation that the algorithms powering our products are built to be safe, transparent, and reliable.
CLOSING THOUGHTS
By freeing heart health from the doctor’s office, we’re making healthcare more convenient and always available.
The more we empower people to track their health anytime and anywhere, the more likely people will be to proactively improve their wellbeing. With these innovations, I hope to see substantive progress in the battle against the world’s biggest killer.
Priya Abani is CEO of AliveCor.